Skip to main content

Scinai Immunotherapeutics Ltd.

SCNI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001611747

No open-market purchases or sales by Scinai Immunotherapeutics Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $49.1K in total; no superinvestor holds it.

Superinvestors holding SCNI, Q2 2026

See all superinvestors

No superinvestor reported holding SCNI in Q2 2026.